glp 1 & gip Frontiers GLP-1 & GIP Agonists |
Description
Concurrent use of DPP-4 inhibitors with a GLP-1 receptor agonist or a dual GIP and GLP-1 receptor agonist is not recommended due to lack of additional glucos...
This statement has not been evaluated by the Food and Drug Administration
Independent editorial review not affiliated with the brand
The use of GLP-1RA is a new therapeutic strategy that addresses both metabolic and cognitive/neuropsychiatric aspects, which is fundamentally important for the treatment of comorbid diseases.
Read the Bloomberg article here...
